Related Experiment Video
Updated: May 17, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Targeting CSC-related miRNAs for cancer therapy by natural agents
Bin Bao1, Yiwei Li, Aamir Ahmad
1Departments of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
Abstract:
The theory of cancer stem cells (CSCs) has provided evidence on fundamental clinical implications because of the involvement of CSCs in cell migration, invasion, metastasis, and treatment resistance, which leads to the poor clinical outcome of cancer patients. Therefore, targeting CSCs will provide a novel therapeutic strategy for the treatment and/or prevention of tumors. However, the regulation of CSCs and its signaling pathways during tumorigenesis are not well understood. MicroRNAs (miRNAs) have been proved to act as key regulators of the post-transcriptional regulation of genes, which involve in a wide array of biological processes including tumorigenesis. The altered expressions of miRNAs are associated with poor clinical outcome of patients diagnosed with a variety of tumors. Therefore, emerging evidence strongly suggest that miRMAs play critical roles in tumor development and progression. Emerging evidence also suggest that miRNAs participate in the regulation of tumor cell growth, migration, invasion, angiogenesis, drug resistance, and metastasis. Moreover, miRNAs such as let-7, miR-21, miR-22, miR-34, miR-101, miR-146a, and miR-200 have been found to be associated with CSC phenotype and function mediated through targeting oncogenic signaling pathways. In this article, we will discuss the role of miRNAs in the regulation of CSC phenotype and function during tumor development and progression. We will also discuss the potential role of naturally occurring agents (nutraceuticals) as potent anti-tumor agents that are believed to function by targeting CSC-related miRNAs.
Insights
Cancer stem cells (CSCs) drive tumor progression and treatment resistance. MicroRNAs (miRNAs) regulate CSCs, offering potential therapeutic targets, including nutraceuticals, for improved cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Stem Cell Research
Background:
- Cancer stem cells (CSCs) are implicated in tumor metastasis and treatment resistance, leading to poor patient outcomes.
- Understanding CSC regulation is crucial for developing effective cancer therapies.
- MicroRNAs (miRNAs) are key post-transcriptional regulators involved in tumorigenesis and cancer progression.
Purpose of the Study:
- To discuss the regulatory role of miRNAs in cancer stem cell phenotype and function.
- To explore the involvement of miRNAs in tumor development and progression.
- To investigate the potential of nutraceuticals in targeting CSC-related miRNAs for cancer therapy.
Main Methods:
- Literature review of studies on miRNAs, CSCs, and tumorigenesis.
- Analysis of miRNA expression patterns in various tumors.
- Examination of specific miRNAs (e.g., let-7, miR-21, miR-34) associated with CSCs.
- Review of research on nutraceuticals targeting CSC-related miRNAs.
Main Results:
- Altered miRNA expression is linked to poor clinical outcomes in cancer patients.
- Specific miRNAs (let-7, miR-21, miR-22, miR-34, miR-101, miR-146a, miR-200) are associated with CSC phenotype and function.
- miRNAs regulate key processes including tumor cell growth, migration, invasion, angiogenesis, drug resistance, and metastasis.
- Nutraceuticals show potential as anti-tumor agents by targeting CSC-related miRNAs.
Conclusions:
- miRNAs play a critical role in regulating cancer stem cell phenotype and function during tumor development.
- Targeting CSC-related miRNAs represents a promising therapeutic strategy for cancer treatment and prevention.
- Nutraceuticals may offer a novel approach to cancer therapy by modulating CSC-related miRNAs.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules
MicroRNAs
MicroRNAs
Abnormal Proliferation

